CIK 0001504776 · Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800423634
- Phone
- (646) 847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | Miller Steven Clive Chief Financial Officer | Option exercise | +27,731 | 216,411 | ||
| 2025-03-04 | Miller Steven Clive Chief Financial Officer | Sale | −11,684 | $23.52 | $275K | 204,727 |
| 2025-03-04 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −1,321 | 0 | ||
| 2025-03-04 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −5,095 | 8,494 | ||
| 2025-03-04 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −8,880 | 68,078 | ||
| 2025-03-04 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −10,554 | 123,135 | ||
| 2025-03-04 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −1,881 | 88,422 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +26,088 | 48,786 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise 10b5-1 | +3,271 | 52,057 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −27,968 | $23.52 | $658K | 24,089 |
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +175,000 | 199,539 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −159,467 | $23.47 | $3.7M | 40,072 |
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −15,533 | $23.95 | $372K | 24,089 |
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,888 | 0 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −44,640 | 610,896 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Class B Common Stock 10b5-1 | +47,528 | 5,598,002 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −26,088 | 5,571,914 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −3,271 | 114,515 | ||
| 2025-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −175,000 | 5,396,914 | ||
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion 10b5-1 | +26,088 | 48,657 |
Page 14 of 20 · 390 trades